2R Invest ApS: Financial statements 2023
CVR: 39715074
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
2R Invest ApS (CVR 39715074) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,682,080 and a net result of DKK -19,863,579 compared with DKK -3,999,254 the year before. Equity in the 2023 report amounted to DKK 559,914. The solvency ratio was 12.2%.
- Gross Profit
- DKK -1,682,080
- Profit/Loss
- DKK -19,863,579
- Equity
- DKK 559,914
- Total Assets
- DKK 4,593,914
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -1.7M | -19.9M | 560K | - |
| 2022 | - | -1.4M | -4M | 20.4M | - |
| 2021 | - | -1.2M | -2.9M | 24.4M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of July 1, 2023, Direct Invest ApS is registered as an owner of 2R Invest ApS with an ownership share of 100%.
About 2R Invest ApS
2R Invest ApS is a Danish company of the type Anpartsselskab based in Ølstykke, founded in 2018. The company is registered under the industry Investering for egen regning. The company was previously named 2R Vital ApS and Mermaid Medical Vascular ApS. The management consists of Jan Rasmussen. The company is owned by Direct Invest ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -59,515 and a net result of DKK -90,435 compared with DKK 14,440,667 the year before. Equity in the 2026 report amounted to DKK 16,822,746.